
BrainScan is a MedTech startup, that has developed A.I. powered brain scans interpretation solution for digital imaging diagnostics as Computed Tomography to prevent under-reporting problem and prioritizing patients using Augmented Intelligence, by detecting up to 26 brain lesions. We have secured large & tagged brain CT database (dataset cover 250K CT exams with text reports) to develop high quality neural networks architecture for autonomous brain scans interpretation. Clinical Evaluation (POC) was introduced in October 2020. Since 2019, BrainScan CT - decision support system for the interpretation of head computed tomography based on machine learning is a medical product labeling the CE2274 mark. BrainScan company develope a high quality product, as evidenced by received certificates confirming compliance with the requirements of the ISO13485: 2016 standard and the requirements of the MDD 93/42 / EEC Directive. In 2023, we obtained CE MDR 2017/ 745 medical certification, product class IIa.

BrainScan is a MedTech startup, that has developed A.I. powered brain scans interpretation solution for digital imaging diagnostics as Computed Tomography to prevent under-reporting problem and prioritizing patients using Augmented Intelligence, by detecting up to 26 brain lesions. We have secured large & tagged brain CT database (dataset cover 250K CT exams with text reports) to develop high quality neural networks architecture for autonomous brain scans interpretation. Clinical Evaluation (POC) was introduced in October 2020. Since 2019, BrainScan CT - decision support system for the interpretation of head computed tomography based on machine learning is a medical product labeling the CE2274 mark. BrainScan company develope a high quality product, as evidenced by received certificates confirming compliance with the requirements of the ISO13485: 2016 standard and the requirements of the MDD 93/42 / EEC Directive. In 2023, we obtained CE MDR 2017/ 745 medical certification, product class IIa.
Headquarters: Gdańsk/Gdynia area, Poland
Founded: 2017
Product: BrainScan CT — AI system for automated analysis of brain CT (detects ~26–30 pathologies)
Regulatory status: CE MDR certified (EU), product class IIa
Company status: Public on Warsaw Stock Exchange NewConnect (ticker: BSN)
Medical imaging diagnostics (brain CT interpretation; hemorrhage, stroke, tumors, other pathologies).
2017
MedTech / Health AI
€2.64M
Grant to improve contrast-enhanced CT analysis and tumor detection
PLN 6,000,000 (~$1.5M)
Raised via public issue of shares managed by Dom Maklerski Navigator S.A.; shares listed on NewConnect (ticker: BSN)
“Institutional and retail shareholders including Cyber Mind VC and family foundation holdings reported”